• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺肠型腺癌:9例临床病理及分子状态研究

Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.

作者信息

Wang Cai-Xia, Liu Biao, Wang Yan-Fen, Zhang Ru-Song, Yu Bo, Lu Zhen-Feng, Shi Qun-Li, Zhou Xiao-Jun

机构信息

Department of Pathology, Clinical School of Medical College of Nanjing University, Nanjing Jingling Hospital Nanjing, China.

出版信息

Int J Clin Exp Pathol. 2014 Feb 15;7(3):1266-74. eCollection 2014.

PMID:24696747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3971340/
Abstract

Pulmonary enteric adenocarcinoma (PEAC), a extremely rare variant of primary invasive adenocarcinoma of the lung, was recognized by the international multidisciplinary classification of lung adenocarcinoma which was proposed by the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS) published in early 2011. Histologically, PEAC is considered to be mainly composed of tall columnar cells arranged in an irregular glandular cavity or cribriform pattern with extensive central necrosis which show high resemblance to that of intestinal epithelia and colorectal carcinomas. Immunohistochemically, PEAC can not only expresses typical proteins common to lung primaries but is positive for at least one intestinal markers, such as CDX2, cytokeratin (CK) 20, MUC2, therefore, the differentiation of primary PEACs from metastatic colorectal cancers can be challenging. In this study, we report 9 cases of PEAC and a panel of immunohistochemical protein markers of CK7, CK20, thyroid transcription factor 1 (TTF-1), Napsin A, MUC2 and villin was analyzed with the comparison of 20 metastatic colorectal carcinomas (MCRs), and 20 typical primary adenocarcinomas (tPACs). As was expected, CK7 expression was documented in all 9 PEACs and 20 tPCAs while CK20 was significantly more prevalent in adenocarcinoma that originated from colorectal. Additionally, we evaluate the classical mutations of EGFR, KRAS in the 9 cases of PEACs, it turned out that all tumors were EGFR-wild and KRAS-wild types, which confirmed that PEAC has a separate phenotype from usual pulmonary adenocarcinoma.

摘要

肺肠型腺癌(PEAC)是原发性肺浸润性腺癌中一种极其罕见的变异类型,它是由国际肺癌研究协会(IASLC)、美国胸科学会(ATS)和欧洲呼吸学会(ERS)于2011年初提出的国际多学科肺腺癌分类所认可的。从组织学上看,PEAC被认为主要由高柱状细胞组成,这些细胞排列在不规则的腺腔或筛状模式中,并伴有广泛的中央坏死,这与肠上皮和结直肠癌的表现高度相似。免疫组化方面,PEAC不仅表达肺原发性肿瘤常见的典型蛋白,而且至少对一种肠道标志物呈阳性,如CDX2、细胞角蛋白(CK)20、MUC2,因此,将原发性PEAC与转移性结直肠癌区分开来可能具有挑战性。在本研究中,我们报告了9例PEAC病例,并分析了一组免疫组化蛋白标志物,包括CK7、CK20、甲状腺转录因子1(TTF-1)、Napsin A、MUC2和绒毛蛋白,并与20例转移性结直肠癌(MCR)和20例典型原发性腺癌(tPAC)进行了比较。正如预期的那样,所有9例PEAC和20例tPCA中均检测到CK7表达,而CK20在源自结肠的腺癌中明显更为普遍。此外,我们评估了9例PEAC病例中EGFR、KRAS的经典突变情况,结果发现所有肿瘤均为EGFR野生型和KRAS野生型,这证实了PEAC具有与常见肺腺癌不同的表型。

相似文献

1
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.肺肠型腺癌:9例临床病理及分子状态研究
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1266-74. eCollection 2014.
2
Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.肺肠型腺癌的临床病理和遗传学分析。
J Clin Pathol. 2024 Jan 18;77(2):111-115. doi: 10.1136/jcp-2022-208583.
3
Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.原发性肺肠型腺癌与切除标本中浸润性腺癌的临床病理、影像学及致癌特征比较
Medicine (Baltimore). 2017 Sep;96(39):e8153. doi: 10.1097/MD.0000000000008153.
4
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.KRAS 基因突变分析和免疫组织化学研究有助于鉴别胰腺转移瘤和原发性肺腺癌。
Mod Pathol. 2014 Feb;27(2):262-70. doi: 10.1038/modpathol.2013.146. Epub 2013 Jul 26.
5
[Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].基于2011年国际多学科肺腺癌分类的分子改变在肺腺癌组织病理学亚型中的相关性
Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):505-10. doi: 10.3760/cma.j.issn.0529-5807.2012.08.001.
6
CDX-2 Expression in Primary Lung Adenocarcinoma.原发性肺腺癌中的CDX-2表达
Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):16-9. doi: 10.1097/PAI.0000000000000250.
7
Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.验证 IASLC/ATS/ERS 肺腺癌分类对预后的影响及其与 EGFR 和 KRAS 基因突变的关系:440 例日本患者的分析。
J Thorac Oncol. 2013 Jan;8(1):52-61. doi: 10.1097/JTO.0b013e3182769aa8.
8
Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status.肺腺癌:通过免疫组织化学以及表皮生长因子受体(EGFR)、人表皮生长因子受体2(HER2)和 Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变状态进行持续亚型分类。
Rev Port Pneumol (2006). 2015 May-Jun;21(3):113-25. doi: 10.1016/j.rppnen.2014.09.009. Epub 2015 Mar 11.
9
Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.具有肠化生的肺腺癌:与转移性结直肠癌及普通肺腺癌相比的组织学和免疫组化特征
Am J Surg Pathol. 2005 May;29(5):660-5. doi: 10.1097/01.pas.0000160438.00652.8b.
10
Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.肺肠型腺癌的临床病理、免疫组化及突变分析:SATB2和β-连环蛋白免疫染色在与转移性结直肠癌鉴别诊断中的应用
Hum Pathol. 2017 Jun;64:179-185. doi: 10.1016/j.humpath.2017.04.006. Epub 2017 Apr 21.

引用本文的文献

1
Pulmonary enteric adenocarcinoma with progression disease after second - line therapy: a case report.二线治疗后疾病进展的肺肠型腺癌:一例报告
Front Oncol. 2025 Jan 23;15:1509026. doi: 10.3389/fonc.2025.1509026. eCollection 2025.
2
Pulmonary Enteric Adenocarcinoma: A Very Rare Case Report from Qatar.肺肠型腺癌:卡塔尔的一例罕见病例报告
Case Rep Oncol. 2023 Aug 30;16(1):759-764. doi: 10.1159/000533220. eCollection 2023 Jan-Dec.
3
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes.解读肺腺癌异质性:罕见亚型的病理和临床特征概述
Life (Basel). 2023 May 31;13(6):1291. doi: 10.3390/life13061291.
4
Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database.肺肠型腺癌的临床特征与预后:一项基于中国及监测、流行病学和最终结果(SEER)数据库的回顾性研究
Front Oncol. 2023 Mar 27;13:1099117. doi: 10.3389/fonc.2023.1099117. eCollection 2023.
5
Pulmonary Enteric Adenocarcinoma in a Young Man.一名年轻男性的肺肠型腺癌
Eurasian J Med. 2023 Feb;55(1):93-94. doi: 10.5152/eurasianjmed.2023.22273.
6
Cytoskeletal and Cytoskeleton-Associated Proteins: Key Regulators of Cancer Stem Cell Properties.细胞骨架及细胞骨架相关蛋白:癌症干细胞特性的关键调节因子
Pharmaceuticals (Basel). 2022 Nov 8;15(11):1369. doi: 10.3390/ph15111369.
7
Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases.原发性肺肠型腺癌的诊断与治疗:6例报告
World J Clin Cases. 2021 Oct 26;9(30):9236-9243. doi: 10.12998/wjcc.v9.i30.9236.
8
Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma.一例罕见的肺肠型腺癌合并既往结肠腺癌的肿瘤基因组特征分析
J Pers Med. 2021 Aug 4;11(8):768. doi: 10.3390/jpm11080768.
9
Cytoskeletal Remodeling in Cancer.癌症中的细胞骨架重塑
Biology (Basel). 2020 Nov 7;9(11):385. doi: 10.3390/biology9110385.
10
Pulmonary enteric adenocarcinoma: a literature review.肺肠型腺癌:文献综述
J Thorac Dis. 2020 Jun;12(6):3217-3226. doi: 10.21037/jtd-19-4171.

本文引用的文献

1
Pulmonary enteric adenocarcinoma with villin brush border immunoreactivity: a case report and literature review.肺肠型腺癌伴绒毛蛋白刷状缘免疫反应:病例报告及文献复习。
J Thorac Dis. 2013 Feb;5(1):E17-20. doi: 10.3978/j.issn.2072-1439.2012.06.06.
2
Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.女性从不吸烟者肺腺癌中驱动基因突变的频率随组织学亚型和诊断时的年龄而变化。
Clin Cancer Res. 2012 Apr 1;18(7):1947-53. doi: 10.1158/1078-0432.CCR-11-2511. Epub 2012 Feb 8.
3
High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.韩国男性吸烟肺腺癌患者中 EGFR 突变的高发率:与组织学亚型、EGFR/TTF-1 表达及临床特征的相关性,无肿瘤内异质性。
J Thorac Oncol. 2012 Feb;7(2):323-30. doi: 10.1097/JTO.0b013e3182381515.
4
Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌分类中具有表皮生长因子受体突变的肺腺癌的组织病理学特征。
Arch Pathol Lab Med. 2011 Oct;135(10):1329-34. doi: 10.5858/arpa.2010-0493-OA.
5
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会:肺腺癌国际多学科分类:执行摘要。
Proc Am Thorac Soc. 2011 Sep;8(5):381-5. doi: 10.1513/pats.201107-042ST.
6
Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7.具有肠分化特征的原发性肺腺癌类似于转移性结直肠癌:第二例细胞角蛋白 7 阴性病例报告。
Pathol Res Pract. 2011 Mar 15;207(3):188-91. doi: 10.1016/j.prp.2010.07.005. Epub 2010 Aug 19.
7
Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.原发性肺腺癌伴肠化生酷似转移性结直肠癌:病例报告及文献复习
Am J Clin Pathol. 2009 Jan;131(1):129-33. doi: 10.1309/AJCPB04XWICTFERL.
8
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.KRAS突变作为接受西妥昔单抗治疗的晚期结直肠癌患者的独立预后因素。
J Clin Oncol. 2008 Jan 20;26(3):374-9. doi: 10.1200/JCO.2007.12.5906.
9
Pulmonary intestinal-type adenocarcinoma.肺肠型腺癌
Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):349-51. doi: 10.1510/icvts.2007.168716. Epub 2008 Jan 9.
10
The epidermal growth factor receptor: from development to tumorigenesis.表皮生长因子受体:从发育到肿瘤发生
Differentiation. 2007 Nov;75(9):770-87. doi: 10.1111/j.1432-0436.2007.00238.x.